articleThe LancetMay 26, 2022GREEN OA

Upadacitinib as induction and maintenance therapy for moderately to severely active ulcerative colitis: results from three phase 3, multicentre, double-blind, randomised trials

IRCCS Ospedale San Raffaele · KU Leuven · +18 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

582
total citations
FWCI
96.75
Percentile
100%
References
29
Citations per year

Authors

23

Topics & keywords

Keywords
  • Medicine
  • Ulcerative colitis
  • Internal medicine
  • Maintenance therapy
  • Placebo
  • Clinical trial
  • Population
  • Phases of clinical research
No related works found for this paper.